ClinicalTrials.Veeva

Menu

Enhancing Physical Function in Older Adults With Chronic Kidney Disease (EPIC)

Wake Forest University (WFU) logo

Wake Forest University (WFU)

Status

Enrolling

Conditions

Chronic Kidney Diseases

Treatments

Behavioral: Attention
Behavioral: High-Velocity Resistance Training

Study type

Interventional

Funder types

Other

Identifiers

NCT06738394
IRB00118658

Details and patient eligibility

About

The goal of this pilot randomized controlled trial is to examine the feasibility and safety of a 12-week high-velocity resistance training (HVRT) intervention in older adults with chronic kidney disease (CKD) stages 4-5 and to generate preliminary data to inform a future study investigating the efficacy of HVRT for improving muscle power and physical function. Researchers will compare HVRT to an attention control condition consisting of weekly group sessions covering topics on healthy lifestyle. This study seeks to:

  1. Determine whether implementing an HVRT intervention is feasible and safe for mobility-limited older adults with advanced CKD.
  2. Collect preliminary data on the efficacy of HVRT for improving muscle power and physical function in mobility-limited older adults with advanced CKD.

Full description

Older adults with advanced chronic kidney disease (CKD) commonly exhibit severe impairments in physical function (i.e., inability to perform activities of daily living). Muscle power-the product of muscle force and velocity of contraction- is now widely considered to be a critical determinant of physical function in older adults. Despite this, muscle power has been largely overlooked in the aims and outcomes of exercise interventions for patients with CKD. Several clinical trials have shown that high-velocity resistance training (HVRT) programs consisting of functional movements performed "as fast as possible" with low external loads are safe and effective for improving muscle power and physical function in older adults. However, the available evidence on the effects of exercise interventions designed to improve muscle power in patients with CKD is scarce. This study seeks to determine whether an HVRT intervention in mobility-limited older adults with advanced CKD is feasible, safe, and potentially effective for improving muscle power and physical function.

Enrollment

30 estimated patients

Sex

All

Ages

65 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Chronic kidney disease stages 3-5
  • Capacity to complete physical exercise
  • Lives within 20 miles of Wake Forest Reynolda Campus
  • Fluent English speaker
  • Does not plan to travel outside of home area for an extended period of time during study
  • Willing to be randomized to either intervention group
  • Short physical performance battery score of 10 or higher

Exclusion criteria

  • Receiving renal replacement therapy (e.g. hemodialysis, peritoneal dialysis) or anticipated to start renal replacement therapy in the next 6 months
  • Dependent on a wheelchair
  • Current participation in a resistance training program
  • Joint replacement or orthopedic surgery in the previous 6 months or planning to have surgery in the next 6 months months
  • Absolute contraindications to exercise testing according to ACSM:

Acute myocardial infarction within the past 6 months Ongoing unstable angina Uncontrolled cardiac arrhythmia with hemodynamic compromise Active endocarditis Symptomatic severe aortic stenosis Decompensated heart failure Acute pulmonary embolism, pulmonary infarction, or deep venous thrombosis Acute myocarditis or pericarditis Acute aortic dissection

  • Parkinson's disease
  • Respiratory disease requiring oxygen
  • Cancer requiring treatment
  • Currently receiving physical therapy or cardiopulmonary rehabilitation
  • Type I or insulin dependent Type II Diabetes
  • Scoring below 32 points on the Telephone Interview for Cognitive Status (TICS)
  • Site PI/Study Clinician discretion regarding medical status, appropriateness of participation or concern about intervention adherence

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 2 patient groups

High-Velocity Resistance Training (HVRT)
Experimental group
Description:
Those assigned to HVRT will attend three small-group (two to five people) exercise sessions lasting 60-75 minutes per week consisting of upper- and lower-body movements performed with weighted vests, medicine balls, and resistance bands. For all exercises, the concentric phase (muscle-shortening portion) will be performed as quickly as possible while maintaining good form, followed by a 1-second pause and then the eccentric phase (lengthening portion) completed in a slow and controlled fashion. Following completion of the 12-week intervention, all participants will be asked to complete the same baseline tests to assess changes in physical function, body composition, quality of life, and cognitive function outcomes.
Treatment:
Behavioral: High-Velocity Resistance Training
Control Group
Active Comparator group
Description:
Participants randomized to the attention control group will receive dedicated contact, information, and motivation throughout the course of the intervention via weekly group sessions and informational handouts. Each in-person group meeting will last approximately one hour. These group sessions will take place in a classroom/conference room setting and include information on such topics as blood pressure, reading food labels, healthy eating, and memory. The class will be a PowerPoint presentation with incorporated question/answer, lively discussion, and group-bonding activities. Following completion of the 12-week intervention, all participants will be asked to complete the same baseline tests to assess changes in physical function, body composition, quality of life, and cognitive function outcomes.
Treatment:
Behavioral: Attention

Trial contacts and locations

1

Loading...

Central trial contact

Jenna Lauderback

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems